Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd W Miller

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Breast Cancer Research : BCR|January 27, 2019
Molecular and epigenetic profiles of BRCA1-like hormone-receptor-positive breast tumors identified with development and application of a copy-number-based classifierYoudinghuan Chen, Yue Wang, Lucas A Salas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2016
Combined Inhibition of Both p110α and p110β Isoforms of Phosphatidylinositol 3-Kinase Is Required for Sustained Therapeutic Effect in PTEN-Deficient, ER<sup>+</sup> Breast CancerSarah R Hosford, Lloye M Dillon, Stephanie J Bouley, et al.
Oncotarget|April 21, 2017
Therapeutic sensitivity to Rac GTPase inhibition requires consequential suppression of mTORC1, AKT, and MEK signaling in breast cancerRiley A Hampsch, Kevin Shee, Darcy Bates, et al.
Cancer Research|August 23, 2013
Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancerJustin M Balko, Luis J Schwarz, Neil E Bhola, et al.
British Journal of Clinical Pharmacology|September 27, 2022
Tumour, whole-blood, plasma and tissue concentrations of metformin in lung cancer patientsJoseph D Phillips, Darcy B Pooler, Dylan B Ness, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
Endocrine therapy induces oxidative stress in ER+ breast cancer that sensitizes persister cells to ferroptosisSteven Tau, Malone Friedman, Alyssa M Roberts, et al.
Experimental and Molecular Pathology|April 21, 2016
Targeted next-generation sequencing detects a high frequency of potentially actionable mutations in metastatic breast cancersKristen E Muller, Jonathan D Marotti, Francine B de Abreu, et al.
Molecular Oncology|June 11, 2019
Estrogen therapy induces an unfolded protein response to drive cell death in ER+ breast cancerSarah R Hosford, Kevin Shee, Jason D Wells, et al.
Marine Pollution Bulletin|March 15, 2011
Hypoxia in Manila Bay, Philippines during the northeast monsoonGil S Jacinto, Lara Patricia A Sotto, Maria Isabel S Senal, et al.
Molecular Cancer Therapeutics|August 11, 2012
Discordant cellular response to presurgical letrozole in bilateral synchronous ER+ breast cancers with a KRAS mutation or FGFR1 gene amplificationJustin M Balko, Ingrid A Mayer, Melinda E Sanders, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Breast Cancer Research : BCR|January 27, 2019
Molecular and epigenetic profiles of BRCA1-like hormone-receptor-positive breast tumors identified with development and application of a copy-number-based classifierYoudinghuan Chen, Yue Wang, Lucas A Salas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2016
Combined Inhibition of Both p110α and p110β Isoforms of Phosphatidylinositol 3-Kinase Is Required for Sustained Therapeutic Effect in PTEN-Deficient, ER<sup>+</sup> Breast CancerSarah R Hosford, Lloye M Dillon, Stephanie J Bouley, et al.
Oncotarget|April 21, 2017
Therapeutic sensitivity to Rac GTPase inhibition requires consequential suppression of mTORC1, AKT, and MEK signaling in breast cancerRiley A Hampsch, Kevin Shee, Darcy Bates, et al.
Cancer Research|August 23, 2013
Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancerJustin M Balko, Luis J Schwarz, Neil E Bhola, et al.
British Journal of Clinical Pharmacology|September 27, 2022
Tumour, whole-blood, plasma and tissue concentrations of metformin in lung cancer patientsJoseph D Phillips, Darcy B Pooler, Dylan B Ness, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
Endocrine therapy induces oxidative stress in ER+ breast cancer that sensitizes persister cells to ferroptosisSteven Tau, Malone Friedman, Alyssa M Roberts, et al.
Experimental and Molecular Pathology|April 21, 2016
Targeted next-generation sequencing detects a high frequency of potentially actionable mutations in metastatic breast cancersKristen E Muller, Jonathan D Marotti, Francine B de Abreu, et al.
Molecular Oncology|June 11, 2019
Estrogen therapy induces an unfolded protein response to drive cell death in ER+ breast cancerSarah R Hosford, Kevin Shee, Jason D Wells, et al.
Marine Pollution Bulletin|March 15, 2011
Hypoxia in Manila Bay, Philippines during the northeast monsoonGil S Jacinto, Lara Patricia A Sotto, Maria Isabel S Senal, et al.
Molecular Cancer Therapeutics|August 11, 2012
Discordant cellular response to presurgical letrozole in bilateral synchronous ER+ breast cancers with a KRAS mutation or FGFR1 gene amplificationJustin M Balko, Ingrid A Mayer, Melinda E Sanders, et al.
Pageof 9